V
Voronoi Inc
KOSDAQ:310210
Voronoi Inc
KOSDAQ:310210
Price:
353 000
KRW
1.58%
Market Closed
Market Cap:
₩6.5T
Voronoi Inc
Goodwill
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Voronoi Inc
Goodwill Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Goodwill | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Goodwill
₩0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Goodwill
₩11.7T
|
CAGR 3-Years
567%
|
CAGR 5-Years
422%
|
CAGR 10-Years
129%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Goodwill
₩2.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Voronoi Inc
Glance View
Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company is headquartered in Incheon, Incheon. The company went IPO on 2022-06-24. The firm is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The firm is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.
Intrinsic Value
10 111.03
KRW
Overvaluation 97%
V
See Also
What is Voronoi Inc's Goodwill?
Goodwill
0
KRW
0
KRW
Based on the financial report for Dec 31, 2024, Voronoi Inc's Goodwill amounts to 0 KRW.
